Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Ann Surg ; 278(3): 328-336, 2023 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-37389551

RESUMEN

OBJECTIVE: We examined trainees in surgery and internal medicine who received National Institutes of Health (NIH) F32 postdoctoral awards to determine their success rates in obtaining future NIH funding. BACKGROUND: Trainees participate in dedicated research years during residency (surgery) and fellowship (internal medicine). They can obtain an NIH F32 grant to fund their research time and have structured mentorship. METHODS: We collected NIH F32 grants (1992-2021) for Surgery Departments and Internal Medicine Departments from NIH RePORTER, an online database of NIH grants. Nonsurgeons and noninternal medicine physicians were excluded. We collected demographic information on each recipient, including gender, current specialty, leadership positions, graduate degrees, and any future NIH grants they received. A Mann-Whitney U test was used for continuous variables, and a χ 2 test was utilized to analyze categorical variables. An alpha value of 0.05 was used to determine significance. RESULTS: We identified 269 surgeons and 735 internal medicine trainees who received F32 grants. A total of 48 surgeons (17.8%) and 339 internal medicine trainees (50.2%) received future NIH funding ( P < 0.0001). Similarly, 24 surgeons (8.9%) and 145 internal medicine trainees (19.7%) received an R01 in the future ( P < 0.0001). Surgeons who received F32 grants were more likely to be department chair or division chiefs ( P =0.0055 and P < 0.0001). CONCLUSIONS: Surgery trainees who obtain NIH F32 grants during dedicated research years are less likely to receive any form of NIH funding in the future compared with their internal medicine colleagues who received F32 grants.


Asunto(s)
Investigación Biomédica , Cirujanos , Estados Unidos , Humanos , National Institutes of Health (U.S.) , Medicina Interna , Mentores
2.
Ann Plast Surg ; 90(6S Suppl 4): S426-S429, 2023 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-37332215

RESUMEN

BACKGROUND: Total wrist arthroplasty (TWA) is a motion-sparing treatment for pancarpal arthritis; however, complication rates up to 50% have limited widespread use. Implant micromotion, stress shielding, and periprosthetic osteolysis result in implant failure and revision to arthrodesis. Metal 3-dimensional (3D) printing allows for more accurate matching of surrounding bone biomechanical properties, theoretically reducing periprosthetic osteolysis. Herein, we use computed tomography to characterize the relationship of relative stiffness along the length of the distal radius with patient demographic factors. METHODS: After institutional review, wrist computed tomography scans at a single institution between 2013 and 2021 were identified. Exclusion criteria were history of radius or carpal trauma or fracture. Collected demographics included age, sex, and comorbidities (including osteoporosis/osteopenia). Scans were analyzed using Materialize Mimics Innovation Suite 24.0 (Leuven, Belgium). Distal radius cortical density (in Hounsfield units) and medullary volume (in cubic millimeters) with relation to distance from the radiocarpal joint were recorded. Average values for each variable were used to 3D-printed distal radius trial components with stiffness matched to bone density by length. RESULTS: Thirty-two patients met inclusion criteria. Distal radius cortical bone density progressively increased proximal to the radiocarpal joint, whereas medullary volume decreased; changes in both plateaued 20 mm proximal to the joint. Distal radius material properties differed by age, sex, and comorbidities. Total wrist arthroplasty implants were fabricated to match these variables as proof of concept. CONCLUSIONS: Distal radius material properties vary along the bone length; conventional implants do not account for this variance. This study showed 3D-printed implants can be created to match bone properties along the length of the implant.


Asunto(s)
Artroplastia de Reemplazo , Prótesis Articulares , Osteólisis , Humanos , Muñeca/cirugía , Osteólisis/cirugía , Rango del Movimiento Articular , Articulación de la Muñeca/diagnóstico por imagen , Articulación de la Muñeca/cirugía , Radio (Anatomía)/cirugía
3.
J Craniofac Surg ; 34(5): 1511-1514, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37307540

RESUMEN

BACKGROUND: Palatoplasty procedures used to repair cleft palates are commonly associated with limiting postoperative pain. Regional anesthetic blocks have been utilized to improve pain outcomes and decrease opioid intake, yet additional data is needed to fully explore its utility in this setting. OBJECTIVE: To explore whether ultrasound-guided suprazygomatic maxillary blocks (SMB) improve postoperative pain, postoperative opioid use, time to oral feeding, and length of stay compared with a palatal field block in cleft palate repair. METHODS: In this retrospective chart review, 47 patients aged 9 to 25 months who underwent cleft palate repair between 2013 and 2020 were allocated into 2 groups: a control group where patients received only palatal local anesthetic in a field block fashion (N=29), and Maxillary block group who received ultrasound-guided SMB (N=18). Patients were matched by age and cleft Veau type. The primary outcomes were total postoperative morphine equivalent consumption, average pain scores, length of stay, and time to first oral feed. RESULTS: Comparing field block versus SMB groups, there was not a statistical difference in the overall dose of postoperative morphine equivalent opioid administration (11.71 vs. 13.36 mg; P =0.483), average pain scores (5.78 vs. 5.27; P =0.194), time to first oral feed [17.21 vs. 14.48 h; P =0.407, 95% CI: (-3.85, 9.32)] or length of stay ( P =0.292). CONCLUSION: The use of SMBs did not demonstrate a difference in the postoperative outcomes evaluated by this study. Further study is needed to define its utility in cleft palate repair.


Asunto(s)
Fisura del Paladar , Humanos , Lactante , Fisura del Paladar/cirugía , Analgésicos Opioides/uso terapéutico , Estudios Retrospectivos , Nervio Maxilar , Anestésicos Locales , Dolor Postoperatorio/tratamiento farmacológico , Dolor Postoperatorio/prevención & control , Morfina
4.
Facial Plast Surg Clin North Am ; 32(2): 271-279, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38575285

RESUMEN

The forehead flap is a time-tested and robust resurfacing flap used for nasal reconstruction. Owing to its excellent color and texture match, acceptable donor site morbidity, and robust and independent blood supply that can support both structural and internal lining grafts, this flap remains the workhorse flap for resurfacing large nasal defects. Various nuances of this technique relating to defect and template preparation, flap design, flap elevation, flap inset, donor site closure, and pedicle division are discussed in this article. These nuances are the guiding principles for improved outcomes using a forehead flap for the reconstruction of large nasal defects.


Asunto(s)
Neoplasias Nasales , Rinoplastia , Humanos , Rinoplastia/métodos , Frente/cirugía , Nariz/cirugía , Colgajos Quirúrgicos/irrigación sanguínea , Neoplasias Nasales/cirugía
5.
Ann Glob Health ; 86(1): 51, 2020 05 18.
Artículo en Inglés | MEDLINE | ID: mdl-32477887

RESUMEN

The developed countries of the world were ill-prepared for the pandemic that they have suffered. When we compare developed to developing countries, the sophisticated parameters we use do not necessarily address the weaknesses in the healthcare systems of developed countries that make them susceptible to crises like the present pandemic. We strongly suggest that better preparation for such events is necessary for a country to be considered developed.


Asunto(s)
Infecciones por Coronavirus/epidemiología , Atención a la Salud , Países Desarrollados/clasificación , Reglamento Sanitario Internacional , Pandemias , Neumonía Viral/epidemiología , Salud Pública , Betacoronavirus/aislamiento & purificación , COVID-19 , Defensa Civil/organización & administración , Defensa Civil/normas , Atención a la Salud/organización & administración , Atención a la Salud/normas , Humanos , Reglamento Sanitario Internacional/organización & administración , Reglamento Sanitario Internacional/normas , Salud Pública/normas , SARS-CoV-2
6.
Cell Rep ; 23(10): 3021-3030, 2018 06 05.
Artículo en Inglés | MEDLINE | ID: mdl-29874587

RESUMEN

Type 2 diabetes (T2D) is associated with increased risk for atherosclerosis; however, the mechanisms underlying this relationship are poorly understood. Macrophages, which are activated in T2D and causatively linked to atherogenesis, are an attractive mechanistic link. Here, we use proteomics to show that diet-induced obesity and insulin resistance (obesity/IR) modulate a pro-atherogenic "macrophage-sterol-responsive-network" (MSRN), which, in turn, predisposes macrophages to cholesterol accumulation. We identify IFNγ as the mediator of obesity/IR-induced MSRN dysregulation and increased macrophage cholesterol accumulation and show that obesity/IR primes T cells to increase IFNγ production. Accordingly, myeloid cell-specific deletion of the IFNγ receptor (Ifngr1-/-) restores MSRN proteins, attenuates macrophage cholesterol accumulation and atherogenesis, and uncouples the strong relationship between hyperinsulinemia and aortic root lesion size in hypercholesterolemic Ldlr-/- mice with obesity/IR, but does not affect these parameters in Ldlr-/- mice without obesity/IR. Collectively, our findings identify an IFNγ-macrophage pathway as a mechanistic link between obesity/IR and accelerated atherogenesis.


Asunto(s)
Aterosclerosis/metabolismo , Aterosclerosis/patología , Resistencia a la Insulina , Interferón gamma/metabolismo , Macrófagos/metabolismo , Obesidad/metabolismo , Obesidad/patología , Animales , Aterosclerosis/genética , Colesterol/metabolismo , Células Espumosas/metabolismo , Regulación de la Expresión Génica , Ratones Endogámicos C57BL , Ratones Noqueados , Células Mieloides/metabolismo , Receptores de Interferón/metabolismo , Receptores de LDL/deficiencia , Receptores de LDL/metabolismo , Receptor de Interferón gamma
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA